Potential Effect of DEPO-PROVERA (medroxyprogesterone acetate injectable suspension, USP) on Bone Mineral Density changes in adults and adolescents - Pfizer Canada Inc.
Issued July 7, 2005
Get notified of similar recallsEnter your email to receive alerts when new recalls are issued by the same agency.
Subscribed. You'll get an email when new recalls are issued.
RecallTracker